Palifermin for the Reduction of Oral Mucositis in Single-dose Evaluation (PROMISE)
A phase 3 trial of Palifermin, Cyclophosphamide and Etoposide in Leukaemia, run by Swedish Orphan Biovitrum, completed.
Overview
Palifermin for the Reduction of Oral Mucositis in Single-dose Evaluation (PROMISE) is a phase 3 interventional study registered as NCT00109031 by Swedish Orphan Biovitrum, with 47 participants recorded, started 2005-01 and reaching its primary completion in 2006-02. Interventions recorded: palifermin, Total Body Irradiation, Cyclophosphamide, Etoposide, Placebo. Conditions recorded: Cancer, Lymphoma, Leukemia.
Linked to the drug Palifermin because the registry names it among its interventions and Leukaemia among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialPalifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer
Shares Palifermin, Sobi (Swedish Orphan Biovitrum) and the tag pipeline.
- TrialA Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Multiple Myeloma
Shares Palifermin, Sobi (Swedish Orphan Biovitrum) and the tag pipeline.
- TrialA Study to Assess the Effect of Maintenance Treatment With Rituximab Versus No Treatment in Participants With Progressive B-Cell Chronic Lymphocytic Leukemia (CLL)
Shares Leukaemia (all types), Cyclophosphamide and the tag pipeline.
- TrialTreatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplasia
Shares Leukaemia (all types), Etoposide, Cyclophosphamide and the tag pipeline.
- TrialPacritinib vs. Hydroxyurea in Advanced Proliferative Chronic Myelomonocytic Leukemia
Shares Sobi (Swedish Orphan Biovitrum) and the tag pipeline.
- TrialCombination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia
Shares Leukaemia (all types), Etoposide, Cyclophosphamide and the tag pipeline.
- TrialCombination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Shares Leukaemia (all types), Etoposide, Cyclophosphamide and the tag pipeline.
- TrialInternational Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia
Shares Leukaemia (all types), Etoposide, Cyclophosphamide and the tag pipeline.